Information for donors
Your generosity will continue to be directed where it matters most: supporting patients and strengthening the safety net they rely on.
A note from Alan Klein, Chief Growth & Strategy Officer
As Chief Growth and Strategy Officer for Patient Advocate Foundation, we are thrilled that patients and their stakeholders will be able to find financial assistance and so many other resources in a single place. I want to reassure you that the core of our work remains unchanged and there will be no disruption of services for patients, including financial assistance grants. This is a tremendous opportunity to expand services, simplify access, and reach millions more people facing the growing healthcare access and affordability crisis here in the U.S.
Below, you can learn more about what our strategic merger means for donors like you, or reach out to me and my team to learn more. We thank you for your continued support as we help patients navigate, access, and afford the care they need.
Alan Klein
Chief Growth & Strategy Officer
Your impact, amplified
As always, we deeply thank you for your generosity and belief in our mission. Your support has always been about one thing: helping patients get the care they need—and that purpose remains unchanged.
The merger of Patient Advocate Foundation and the PAN Foundation allows us to build on that shared mission by reaching more people and offering more comprehensive support. By bringing together complementary programs, expertise, and infrastructure, we’re expanding our ability to respond to rising healthcare costs and growing barriers to care, without losing sight of the individuals and families at the heart of this work.
Your contributions will continue to support the same core mission you’ve invested in: helping patients afford treatment, navigate complex healthcare challenges, and overcome obstacles that stand in the way of care.
Reports and financials
Patient Advocate Foundation
PAN Foundation
TotalAssist
On July 1, 2026, Patient Advocate Foundation launched TotalAssist, the nation’s largest and most comprehensive charitable patient assistance program. Covering nearly 150 serious and chronic conditions, TotalAssist helps patients afford the cost of healthcare with grants to eligible individuals. TotalAssist grants provide patients with flexible-use funding, meaning they can use their grant for the following eligible out-of-pocket healthcare costs:
- Medication copays, coinsurance, and deductibles
- Health insurance premiums
- Office visit charges the day of treatment
- Administration charges the day of treatment
Identified need funds
In addition to the nearly 150 funds for which we have already officially opened and provided financial assistance to patients, Patient Advocate Foundation has identified 300+ disease funds that are awaiting initial donations. These funds were identified through an independent, rigorous research process, including through our case management data. We define our disease funds in accordance with widely recognized clinical standards, specifically using ICD-10 codes to specify the clinical scope and to supplement the definition of a widely recognized disease state.
Patient Advocate Foundation has sole discretion in identifying new disease funds and is not influenced by, nor do we accept, recommendations from donors regarding the design of a disease fund. In addition, we will not create a new disease fund in response to a donor request.
Contact us
Alan Klein, Chief Growth & Strategy Officer, will serve as the primary donor contact to ensure meaningful and transparent donor engagement.
Having raised over $8 billion to directly assist millions of patients with life-threatening, chronic, and rare conditions, Alan is an accomplished strategic development officer and patient advocate with a track record of expertise in access-to-care initiatives and successfully expanding mission impact for nonprofit organizations. As Chief Growth and Strategy Officer at Patient Advocate Foundation, the first comprehensive nonprofit dedicated to helping patients navigate, access, and afford care, he develops and scales support for mission programs and initiatives that expand access to affordable, equitable healthcare and improve health outcomes.
With more than 30 years leading business development and management strategies in the healthcare nonprofit and pharmaceutical sectors, Alan brings a deep commitment to advancing healthcare access, equity, and affordability. Prior to the 2026 strategic merger between Patient Advocate Foundation and the PAN Foundation, Alan served as Chief Growth and Strategy Officer at the PAN Foundation, where he worked to accelerate access to affordable, equitable healthcare through its advocacy, education, and financial assistance programs.
Previously, Alan served as Chief Development Officer at HealthWell Foundation. His career also includes leadership roles in the pharmaceutical sector managing large-scale transactions, revenue growth, and strategic product development. Throughout his career, Alan has spent more than 30 years in senior-level business/corporate development and management positions at pre-revenue, small, and large organizations within the pharmaceutical and biotechnology industries. In addition, he has been responsible for the management of revenue growth and portfolio investments, profit management, and supervision of strategic product development programs in these prior roles.
Alan received his MBA from Johns Hopkins University and a BA from the University of Maryland.
"*" indicates required fields
Help center
Use our TotalAssist help center to find answers to questions about grants and claims.
News
Read the latest news about our merger and programs, access our media kit, and sign up for updates.
Contact us
Reach out with any questions or concerns. We will get in touch with you as quickly as possible.